|
|
||||||||

*
Division of Tumor Immunology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, MA 02115; and
Department of Clinical Immunology and AIDS Research Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan
Crk-associated substrate (Cas) lymphocyte-type (Cas-L) is a 105-kDa cytoplasmic protein consisting of Src homology-3 domain and multiple YXXP motifs (substrate domain). Our previous studies showed that Cas-L is tyrosine-phosphorylated following the ligation of TCR and ß1 integrins in T lymphocytes. Here we show that Cas-L is involved in T cell motility following the ligation of TCR and ß1 integrin. Peripheral T lymphocytes showed a marked increase of migration on fibronectin (FN) after the ligation of TCR. In contrast, the migrating Jurkat cells, in which Cas-L was marginally expressed, were less than one-tenth in number on the same condition. Transfection of wild-type Cas-L into Jurkat cells resulted in restoring CD3 plus FN-induced cell migration. Furthermore, following the ligation of ß1 integrin alone, the Cas-L transfectants significantly migrated better than the vector control. Mutational analysis of Cas-L revealed that the substrate domain is required for both FN- and CD3-induced tyrosine phosphorylation of Cas-L and cell migration caused by FN alone and CD3 plus FN. In contrast, the Src homology-3 domain is required only for the FN-induced tyrosine phosphorylation of Cas-L and cell migration, but not for CD3-induced tyrosine phosphorylation or CD3 plus FN-induced cell migration. These data strongly suggest that Cas-L is a key molecule in T cell migration induced by the ligation of CD3 and ß1 integrins and that tyrosine phosphorylation of Cas-L is essential for T cell migration.
This article has been cited by other articles:
![]() |
M. Zheng and P. J. McKeown-Longo Cell adhesion regulates Ser/Thr phosphorylation and proteasomal degradation of HEF1 J. Cell Sci., January 1, 2006; 119(1): 96 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ambrogio, C. Voena, A. D. Manazza, R. Piva, L. Riera, L. Barberis, C. Costa, G. Tarone, P. Defilippi, E. Hirsch, et al. p130Cas mediates the transforming properties of the anaplastic lymphoma kinase Blood, December 1, 2005; 106(12): 3907 - 3916. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sasaki, S. Iwata, H. J. Okano, Y. Urasaki, J. Hamada, H. Tanaka, N. H. Dang, H. Okano, and C. Morimoto Nedd9 Protein, a Cas-L Homologue, Is Upregulated After Transient Global Ischemia in Rats: Possible Involvement of Nedd9 in the Differentiation of Neurons After Ischemia Stroke, November 1, 2005; 36(11): 2457 - 2462. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Seo, T. Asai, T. Saito, T. Suzuki, Y. Morishita, T. Nakamoto, M. Ichikawa, G. Yamamoto, M. Kawazu, T. Yamagata, et al. Crk-Associated Substrate Lymphocyte Type Is Required for Lymphocyte Trafficking and Marginal Zone B Cell Maintenance J. Immunol., September 15, 2005; 175(6): 3492 - 3501. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hogg, M. Laschinger, K. Giles, and A. McDowall T-cell integrins: more than just sticking points J. Cell Sci., December 1, 2003; 116(23): 4695 - 4705. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Klein, M. Zheng, A. Ambesi, L. Van De Water, and P. J. McKeown-Longo Stimulation of extracellular matrix remodeling by the first type III repeat in fibronectin J. Cell Sci., November 15, 2003; 116(22): 4663 - 4674. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sharfe, A. Freywald, A. Toro, and C. M. Roifman Ephrin-A1 Induces c-Cbl Phosphorylation and EphA Receptor Down-Regulation in T Cells J. Immunol., June 15, 2003; 170(12): 6024 - 6032. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sakakibara, S. Hattori, S. Nakamura, and T. Katagiri A Novel Hematopoietic Adaptor Protein, Chat-H, Positively Regulates T Cell Receptor-mediated Interleukin-2 Production by Jurkat Cells J. Biol. Chem., February 14, 2003; 278(8): 6012 - 6017. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zheng and P. J. McKeown-Longo Regulation of HEF1 Expression and Phosphorylation by TGF-beta 1 and Cell Adhesion J. Biol. Chem., October 11, 2002; 277(42): 39599 - 39608. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Suzuki, T. Nakamoto, S. Ogawa, S. Seo, T. Matsumura, K. Tachibana, C. Morimoto, and H. Hirai MICAL, a Novel CasL Interacting Molecule, Associates with Vimentin J. Biol. Chem., April 19, 2002; 277(17): 14933 - 14941. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Fashena, M. B. Einarson, G. M. O'Neill, C. Patriotis, and E. A. Golemis Dissection of HEF1-dependent functions in motility and transcriptional regulation J. Cell Sci., January 1, 2002; 115(1): 99 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Law, G. M. O'Neill, S. J. Fashena, M. B. Einarson, and E. A. Golemis The Docking Protein HEF1 Is an Apoptotic Mediator at Focal Adhesion Sites Mol. Cell. Biol., July 15, 2000; 20(14): 5184 - 5195. [Abstract] [Full Text] |
||||
![]() |
F. Aoudjit and K. Vuori Engagement of the alpha 2beta 1 integrin inhibits Fas ligand expression and activation-induced cell death in T cells in a focal adhesion kinase-dependent manner Blood, March 15, 2000; 95(6): 2044 - 2051. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |